We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 389

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 13 2013

This case involved a dispute over ownership and alleged infringement of copyright in a number of computer software programs. The Court held that the

Prohibition not granted as non-infringement allegation held justified

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 18 2012

The Court heard this application and the next application consecutively and issued decisions on the same day, however, indicated that each was considered separately

Intellectual property weekly abstracts bulletin

  • Borden Ladner Gervais LLP
  • -
  • Canada, USA
  • -
  • May 22 2013

The Supreme Court has dismissed Eli Lilly of Canada Inc.’s leave on the issue, as summarized by the Court, as to whether the creation by the Federal

Teva Canada Innovation v. Attorney General of Canada

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 8 2013

The Patented Medicine Prices Review Board (the PMPRB) ordered Teva to pay the Crown approximately $2.4 million for selling its product at an

Reynolds Presto Products Inc. v. P.R.S. Mediterranean Ltd., 2013 FCA 119

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 8 2013

The Court of Appeal has overturned a lower court decision and struck the mark NEOWEB from the register because it is confusing with the earlier

Compound patent found valid in face of allegations of lack of utilitysound prediction and insufficiency

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 27 2013

Apotex and Novopharm started actions to impeach Novartis’ patent covering the compound imatinib, sold under the brand name GLEEVEC. They then sent

Motion for interlocutory injunction, declaration and production of documents denied

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 30 2013

Ryan is a 75 shareholder in the plaintiff company who carries on business as “Bloor Street Boxing & Fitness”. The

Appeal of prothonotary’s decision refusing reversal of evidence dismissed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • December 12 2011

AstraZeneca brought a motion before the Case Management Prothonotary, seeking a reversal of the order in which the evidence was presented

Patent application rejected again for obviousness

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • May 28 2012

The Commissioner had previously refused the patent application on the basis of obviousness

Motion to reopen trial to introduce new evidence denied

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • October 24 2011

This is a motion by the Defendants, seeking to reopen the trial

Current Search

Suggested Facets

Author

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy